Warning: include() [function.include]: URL file-access is disabled in the server configuration in /home/antinode/public_html/wp-content/themes/wp-medical-doctor/sidebar.php on line 67
Warning: include(http://www.linkworth.com/act/partner/code/linkad_ads.php?web_id=50291&loc_id=1&pla_id=91825&link_format=6&hash=5acb1640bc0fe77ecb396679deed017b) [function.include]: failed to open stream: no suitable wrapper could be found in /home/antinode/public_html/wp-content/themes/wp-medical-doctor/sidebar.php on line 67
Warning: include() [function.include]: Failed opening 'http://www.linkworth.com/act/partner/code/linkad_ads.php?web_id=50291&loc_id=1&pla_id=91825&link_format=6&hash=5acb1640bc0fe77ecb396679deed017b' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/antinode/public_html/wp-content/themes/wp-medical-doctor/sidebar.php on line 67
, according to a new report in the journal
. The child had a rare, deadly brain disease called ataxia telangiectasia, or A-T. The disease can lead to degeneration of a region of the brain; most people with A-T die by their teens or early 20s. The boy had traveled to Russia at age 9, when he was injected with fetal neural stem cells in his brain and spinal cord, the Associated Press reports. He received two additional sets of injections at ages 10 Read the rest of this entry »
of breast cancer in Norwegian women suggests that some breast tumors may regress on their own over time, the
reports. The study — published Tuesday in the
— followed two groups of more than 100,000 Norwegian women ages 50 to 64 for two consecutive periods: from 1992 to 1997 and from 1996 to 2001. Norway initiated mammography screening in 1996 (Kolata,
, 11/25). Researchers compared invasive breast cancer rates among the first group — who Read the rest of this entry »
ScienceDaily (Feb. 22, 2009)
— Small is promising when it comes to illuminating tiny tumors or precisely delivering drugs, but many worry about the safety of nano-scale materials. Now a team of scientists has created miniscule flakes of silicon that glow brightly, last long enough to slowly release cancer drugs, then break down into harmless by-products.
“It is the first luminescent nanoparticle that was purposely designed to minimize toxic Read the rest of this entry »
ScienceDaily (Nov. 12, 2008)
— According to Oregon Health & Science University Knight Cancer Institute researchers, there is strong evidence that patients can have varying clinical responses to medications depending on the specific makeup of their cancer. The study, which focused on gastrointestinal stromal tumors, also called GIST, found that the genetic variations in their disease appear to determine which medications will be most effective. Read the rest of this entry »
ScienceDaily (Nov. 30, 2008)
— A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches. In their Nature Medicine report, which is receiving early online release, investigators from Dana-Farber Cancer Institute (DFCI), Massachusetts General Hospital (MGH) Cancer Center, and Beth Israel Deaconess Medical Center Read the rest of this entry »